Veloxis Pharmaceuticals, Inc. (Veloxis), a global specialty pharmaceutical company and an Asahi Kasei company, has announced that the United States Adopted Name (USAN) Council has approved the ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

Nucleolin is overexpressed on the surface of cancer cells. AS1411, an aptamer showing specific binding to nucleolin, was conjugated to PEGylated cationic liposome as the targeting probe ASLP ...

Today, a tribunal under the auspices of the International Chamber of Commerce (ICC) served a partial final award in a dispute ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

The Food and Drug Administration (FDA) has expanded the labeling for Izervay™ (avacincaptad pegol intravitreal solution) to include longer-term ...

Institute of Advanced Technology, Westlake Institute for Advanced Study, Hangzhou 310024, Zhejiang, China School of Engineering, Westlake University, Hangzhou 310030, Zhejiang, China Institute of ...

CD Bioparticles recently announced the availability of its new line of Exosome Extraction Kits. NEW YORK, NY, UNITED STATES, February 21, 2025 ...

Learn more about whether BioMarin Pharmaceutical Inc. or Insmed Incorporated is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.